Risk adjusted net present value: What is the current valuation of AstraZeneca’s Saruparib?

Saruparib is a small molecule commercialized by AstraZeneca, with a leading Phase III program in Metastatic Prostate Cancer.

Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

October 27, 2023

Protesters slam health insurance lobby for Medicare Advantage coverage restrictions

WASHINGTON — Hundreds of activists rallied today outside of the headquarters of the country’s largest health insurance lobbying group to protest against restrictions to coverage

June 27, 2023

How Enthea is Revolutionizing Psychedelic-Assisted Therapy Accessibility feat. Sherry Rais | Psychedelic Spotlight

Most of us have probably heard some version of the saying “a happy and healthy employee is a productive employee”. But requesting a meeting with

July 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.